BIO-key Adjourns Annual Meeting to Oct. 30 as Three Proposals Pass
BIO-key stockholders approved three of four proposals at the reconvened October 2, 2026 annual meeting, including election of five directors and ratification of M&K CPAs, PLLC as auditor. The company adjourned the meeting to October 30, 2026 to give stockholders more time to vote on Proposal 4, which seeks approval for issuing up to 1,236,668 shares from warrants issued in its August 10, 2026 warrant inducement transaction.
Key points
- Proposals 1 to 3 approved: five directors elected, M&K CPAs, PLLC ratified for 2026 (497,275 votes for), and non-binding executive pay approved (175,347 votes for).
- Proposal 4 seeks Nasdaq Listing Rule 5635(d) approval for up to 1,236,668 shares tied to the August 10, 2026 warrant inducement; its polls remain open.
- Reconvened meeting set for October 30, 2026 at 10:00 a.m. local time; 606,778 shares, about 55.8% of 1,087,360 shares entitled to vote, were present at the October 2 session.
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.